Benitec, CSIRO Amend RNAi Licensing Deal

Under the amended deal, Benitec will no longer pay CSIRO royalties, while CSIRO gets a 10 percent stake in the company.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.